anti-CD3/anti-EpCAM bispecific T-cell engager (Crown Bioscience)

N/A

Report date: 2026/03/19 16:53:50

Base Information

Drug Nameanti-CD3/anti-EpCAM bispecific T-cell engager (Crown Bioscience)
Drug Alias NamehCD3 x hEpCAM bispecific antibody (Crown Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsEpithelial cell adhesion molecule modulators
TargetsT cell surface glycoprotein CD3Epithelial cell adhesion molecule
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrown Bioscience(Taicang)Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCrown Bioscience(Taicang)Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A